NBIX vs NEWTH
Neurocrine Biosciences Inc (NBIX) versus NewtekOne, Inc. 8.625% Fixed Rate Senior Notes due 2029 (NEWTH) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
NewtekOne, Inc. 8.625% Fixed Rate Senior Notes due 2029 (NEWTH) common stock listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
NEWTH does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. NEWTH currently screens at market cap $0.
Not investment advice. Open the NBIX and NEWTH stock pages for the full models.
Not investment advice.